Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMJE6N7)

Drug Name	Iseganan DMJE6N7
Synonyms	Iseganan HCl; IB-367; Iseganan (inhalant formulation); PNU-196443; Protegrin IB-367; IB-367-03; Iseganan(inhalant formulation), IntraBiotics; Antimicrobial, IntraBiotics/P&U
Structure
Structure	3D MOL			2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

1 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Head and neck cancer	DISBPSQZ	2D42	Phase 3	[1]
------------------------------------------------------------------------------------

1 Discontinued in Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Bacterial infection	DIS5QJ9S	1A00-1C4Z	Discontinued in Phase 2	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT00022373) Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer. U.S. National Institutes of Health.
2	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800012480)